Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2014

View Archived Issues

Group develops novel small-molecule polymerase inhibitor to contain measle outbreaks

Researchers develop and test novel oral Shigella challenge model

BMS presents oral pan-Notch inhibitor for cancer

First preclinical results for AMA-0428 as treatment for wet AMD

Lysophospholipid LPA2 receptor ligands for radiation injury synthesized

ADC Therapeutics patents novel antibody-drug conjugates for cancer

Connexios Life Sciences and Boehringer Ingelheim form AMPK activator agreement

Azaya Therapeutics enters collaboration for ATI-1123

Phase II data trace path towards development of LTX-109

NanoViricides reports drug candidates for MERS coronavirus infection

IDH1 gene mutation-specific vaccine developed for treatment of patients with glioma

NN-8555 demonstrates efficacy and safety in phase II Crohn's disease trial

FDA accepts MK-3475 BLA for review in advanced melanoma

Cancer Genetics launches hematological cancer diagnostics

Shire outlines progress of first quarter 2014

C-Cure receives EMA certification of quality data

Japanese researchers disclose novel agents for Alzheimer's disease

Bristol-Myers Squibb discloses novel coagulation factor XIa inhibitors

Mologen files clinical trial applications for phase III trial of anticancer immunostimulant

Roche divulges new TRPA1 antagonists

Janssen submits sNDA to FDA for Olysio in combination with sofosbuvir

Novel compounds for HIV infection designed by Laboratoire Biodim

Favorable safety and efficacy of ITI-007 against acutely exacerbated schizophrenia

AbbVie files for E.U. approval of HCV regimen

Pacira files sNDA for nerve block indication for liposomal bupivacaine

Santhera re-files European MAA for Raxone

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...